Sequent Scientific Limited (SEQUENT.NS)
INR 137.18
(3.85%)
INR 137.18
(3.85%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.97 Billion INR | -49.27% |
| 2022 | 5.87 Billion INR | 3.78% |
| 2021 | 5.65 Billion INR | -8.08% |
| 2020 | 6.15 Billion INR | 17.88% |
| 2019 | 5.22 Billion INR | 17.04% |
| 2018 | 4.46 Billion INR | 24.31% |
| 2017 | 3.58 Billion INR | -12.53% |
| 2016 | 4.1 Billion INR | 48.83% |
| 2015 | 2.75 Billion INR | 51.83% |
| 2014 | 1.81 Billion INR | 7.28% |
| 2013 | 1.69 Billion INR | 48.41% |
| 2012 | 1.14 Billion INR | -25.84% |
| 2011 | 1.53 Billion INR | 2.76% |
| 2010 | 1.49 Billion INR | -4.56% |
| 2009 | 1.56 Billion INR | 102.39% |
| 2008 | 774.76 Million INR | 282.82% |
| 2007 | 202.38 Million INR | 40.97% |
| 2006 | 143.56 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 976.2 Million INR | 10.95% |
| 2023 FY | 2.97 Billion INR | -49.27% |
| 2023 Q2 | 1.56 Billion INR | 12.86% |
| 2023 Q1 | 1.38 Billion INR | -4.5% |
| 2023 Q4 | 879.86 Million INR | 16.67% |
| 2023 Q3 | 754.13 Million INR | -51.72% |
| 2022 Q4 | 1.44 Billion INR | -8.21% |
| 2022 Q3 | 1.57 Billion INR | 13.0% |
| 2022 Q1 | 1.44 Billion INR | 30.48% |
| 2022 Q2 | 1.39 Billion INR | -3.39% |
| 2022 FY | 5.87 Billion INR | 3.78% |
| 2021 Q1 | 1.54 Billion INR | 29.3% |
| 2021 FY | 5.65 Billion INR | -8.08% |
| 2021 Q4 | 1.1 Billion INR | -26.37% |
| 2021 Q3 | 1.5 Billion INR | 0.26% |
| 2021 Q2 | 1.5 Billion INR | -2.65% |
| 2020 Q3 | 1.79 Billion INR | 8.58% |
| 2020 Q2 | 1.65 Billion INR | 9.77% |
| 2020 Q1 | 1.5 Billion INR | 52.23% |
| 2020 FY | 6.15 Billion INR | 17.88% |
| 2020 Q4 | 1.19 Billion INR | -33.65% |
| 2019 FY | 5.22 Billion INR | 17.04% |
| 2019 Q3 | 1.54 Billion INR | 15.88% |
| 2019 Q4 | 990.81 Million INR | -35.93% |
| 2019 Q1 | 1.34 Billion INR | 54.15% |
| 2019 Q2 | 1.33 Billion INR | -1.07% |
| 2018 Q4 | 875.16 Million INR | -32.3% |
| 2018 FY | 4.46 Billion INR | 24.31% |
| 2018 Q3 | 1.29 Billion INR | 7.14% |
| 2018 Q2 | 1.2 Billion INR | 11.06% |
| 2018 Q1 | 1.08 Billion INR | 30.01% |
| 2017 Q3 | 1.04 Billion INR | -17.04% |
| 2017 Q2 | 1.25 Billion INR | 0.09% |
| 2017 Q1 | 1.25 Billion INR | -29.78% |
| 2017 FY | 3.58 Billion INR | -12.53% |
| 2017 Q4 | 835.62 Million INR | -19.66% |
| 2016 Q1 | 903.17 Million INR | 69.22% |
| 2016 Q4 | 1.78 Billion INR | 85.38% |
| 2016 Q3 | 962.22 Million INR | -19.66% |
| 2016 FY | 4.1 Billion INR | 48.83% |
| 2016 Q2 | 1.19 Billion INR | 32.6% |
| 2015 Q3 | 743.85 Million INR | -6.16% |
| 2015 Q2 | 792.71 Million INR | 17.72% |
| 2015 FY | 2.75 Billion INR | 51.83% |
| 2015 Q1 | 673.38 Million INR | 116.49% |
| 2015 Q4 | 533.71 Million INR | -28.25% |
| 2014 Q3 | 555.87 Million INR | 25.5% |
| 2014 Q2 | 442.93 Million INR | -5.61% |
| 2014 Q1 | 469.27 Million INR | 769.2% |
| 2014 FY | 1.81 Billion INR | 7.28% |
| 2014 Q4 | 311.05 Million INR | -44.04% |
| 2013 Q3 | 518.52 Million INR | -10.56% |
| 2013 Q4 | 53.99 Million INR | -89.59% |
| 2013 FY | 1.69 Billion INR | 48.41% |
| 2013 Q1 | 522 Million INR | 333.2% |
| 2013 Q2 | 579.73 Million INR | 11.06% |
| 2012 FY | 1.14 Billion INR | -25.84% |
| 2012 Q4 | 120.5 Million INR | -69.23% |
| 2012 Q3 | 391.59 Million INR | 30.31% |
| 2012 Q2 | 300.51 Million INR | -8.31% |
| 2012 Q1 | 327.74 Million INR | 0.0% |
| 2011 FY | 1.53 Billion INR | 2.76% |
| 2010 FY | 1.49 Billion INR | -4.56% |
| 2009 FY | 1.56 Billion INR | 102.39% |
| 2008 FY | 774.76 Million INR | 282.82% |
| 2007 FY | 202.38 Million INR | 40.97% |
| 2006 FY | 143.56 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 88.877% |
| Hester Biosciences Limited | 1.27 Billion INR | -133.874% |
| Aarti Drugs Limited | 8.31 Billion INR | 64.182% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 48.919% |
| Albert David Limited | 1.4 Billion INR | -111.544% |
| Alembic Limited | 1 Billion INR | -197.841% |
| Alkem Laboratories Limited | 52.29 Billion INR | 94.304% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -558.788% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -102.386% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -23644.36% |
| Brooks Laboratories Limited | 65.62 Million INR | -4439.363% |
| Eris Lifesciences Limited | 10.42 Billion INR | 71.432% |
| FDC Limited | 6.58 Billion INR | 54.773% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 76.042% |
| Gufic Biosciences Limited | 4.07 Billion INR | 26.88% |
| Hikal Limited | 5.95 Billion INR | 50.005% |
| Ind-Swift Limited | 2.17 Billion INR | -37.109% |
| Innova Captab Limited | 3.46 Billion INR | 14.02% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | 36.879% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -356.447% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 84.836% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -57.867% |
| Lupin Limited | 125.09 Billion INR | 97.619% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -330.955% |
| Medico Remedies Limited | 262.14 Million INR | -1036.295% |
| Morepen Laboratories Limited | 6.16 Billion INR | 51.654% |
| Nectar Lifesciences Limited | 4.82 Billion INR | 38.243% |
| Orchid Pharma Limited | 2.32 Billion INR | -28.377% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 48.477% |
| RPG Life Sciences Limited | 2.48 Billion INR | -19.965% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -380.071% |
| Sigachi Industries Limited | 2 Billion INR | -48.767% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 279.886% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | 27.758% |
| Themis Medicare Limited | 2.42 Billion INR | -23.088% |
| Unichem Laboratories Limited | 4.86 Billion INR | 38.771% |
| Vaishali Pharma Limited | 90.32 Million INR | -3197.864% |
| Wanbury Limited | 1.73 Billion INR | -72.117% |
| Windlas Biotech Limited | 1.33 Billion INR | -122.493% |
| ZIM Laboratories Limited | 1.26 Billion INR | -134.95% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | 27.932% |
| Ipca Laboratories Limited | 48.58 Billion INR | 93.869% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 98.848% |
| Venus Remedies Limited | 2.18 Billion INR | -36.477% |
| Sakar Healthcare Limited | 699.58 Million INR | -325.785% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 97.281% |
| Divi's Laboratories Limited | 32.44 Billion INR | 90.818% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 52.131% |
| Mankind Pharma Limited | 42.19 Billion INR | 92.941% |
| Laurus Labs Limited | 15.44 Billion INR | 80.719% |
| Neuland Laboratories Limited | 8.24 Billion INR | 63.885% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 80.479% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 95.704% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 97.621% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -42.248% |
| Wockhardt Limited | 7.72 Billion INR | 61.415% |
| Bal Pharma Limited | 770.19 Million INR | -286.75% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 98.179% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | 19.394% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -462.942% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 67.645% |
| Shilpa Medicare Limited | 3.56 Billion INR | 16.372% |
| Valiant Laboratories Limited | 138.02 Million INR | -2058.046% |
| Ajanta Pharma Limited | 21.06 Billion INR | 85.859% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -2535.368% |
| Granules India Limited | 16.79 Billion INR | 82.269% |
| Medicamen Biotech Limited | 495.49 Million INR | -501.162% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -432.389% |
| Piramal Enterprises Limited | 8.04 Billion INR | 62.966% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 93.629% |
| NATCO Pharma Limited | 25.73 Billion INR | 88.426% |
| Suven Life Sciences Limited | -200.79 Million INR | 1583.453% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 2839.138% |
| Strides Pharma Science Limited | 14.38 Billion INR | 79.297% |
| Indoco Remedies Limited | 8.04 Billion INR | 62.965% |
| Alpa Laboratories Limited | 188.89 Million INR | -1476.924% |
| Lasa Supergenerics Limited | 121.02 Million INR | -2361.15% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -661.695% |